An early and non-invasive method for assessing the risk of a subject with pancreatic duct cancer and method of treating such a disease

摘要

Problem to be solved: to provide a pharmaceutical composition for preventing or treating the pancreatic duct gland cancer (PDAC).For use in the prevention or treatment of patients suffering from pancreatic duct glands β A pharmaceutical composition comprising an ig-h3 antagonist and the antagonist β It is a pharmaceutical composition that directly combines with ig-h3 to restore CD8 + T cell activation.No selection